Significance of cytogenetic clonal evolution in chronic myelogenous leukemia

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 196-203

  Majlis, A ^a   Smith, T L ^a   Talpaz, M ^a   O'Brien, S ^a   Rios, M B ^a   Kantarjian, H M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION 17; CHRONIC MYELOID LEUKEMIA; CLONE; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL TIME;

EID: 0030061157     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.196     Document Type: Article

References (15)

1. Kantarjian H, Smith T, McCredie K, et al: Chronic myelogenous leukemia - A multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 66:1326-1335, 1985
2. Sokal J, Gomez G, Baccarani M, et al: Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood 72:294-298, 1988
3. Kantarjian H, Keating M, Smith T, et al: Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J Med 88:1-8, 1990
4. Kantarjian H, Dixon D, Keating MJ, et al: Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer 61:1441-1446, 1988
5. Sessarego M, Panarello P, Coviello DA, et al: Karyotype evolution in CML-High frequency of translocation other than the Ph. Cancer Genet Cytogenet 25:73-80, 1987
6. Swolin B, Weinfeld A, Westin J: Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression. Cancer Genet Cytogenet 18:65-79, 1985
7. Trujillo JM, Cork A, Ahearn MJ: Hematologic and cytologic characterization of 8;21 translocation acute granulocytic leukemia. Blood 53:659-706, 1979
8. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:157-160, 1958
9. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
10. Breiman L, Friedman JH, Olshen RA, et al: Classification and regression trees. Belmont, CA, Wadsworth International, 1984
11. Therneau TM, Grambsch PM, Fleming TR: Martingale based residuals for survival models. Biometrika 77:147-160, 1990
12. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
13. Ahuja H, Bar-Eli M, Arlin Z: The spectrum of molecular alternations in the evolution of chronic myelocytic leukemia. J Clin Invest 87:2042-2047, 1991
14. Foti A, Ahuja HG, Allen SL: Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis. Blood 77:2441-2444, 1991
15. Ahuja H, Bar-Eli M, Advani SH, et al: Alternations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci USA 86:6783-6787, 1989